Both in Biotechnology
Black Hawk Acquisition vs aTyr Pharma
Over the past year BKHA returned −59.8% and ATYR returned −81.5%; their daily moves had a correlation of -0.13.
BKHA −59.8% ATYR −81.5%Growth of $1, one year, split-adjusted
| Metric | BKHA | ATYR |
|---|---|---|
| Price | $4.50 | $6.03 |
| Market cap | $18.7M | $15.1M |
| Today | −19.21% | −2.43% |
| 1 month | −65.4% | −45.8% |
| 6 months | — | −83.6% |
| Year to date | −60.0% | −80.7% |
| 1 year | — | −81.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 79.3× |
| Net cash | — | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 164.3% | 1,072.3% |
| Short % of float | 2.6% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).